Recent Advances in the Genetics of Autoimmune Disease

Overview

Journal Annu Rev Immunol

Specialty Allergy & Immunology

Date 2009 Mar 24

PMID 19302045

Citations 127

Authors

Peter K Gregersen

Lina M Olsson

Affiliations

Soon will be listed here.

Abstract

Extraordinary technical advances in the field of human genetics over the past few years have catalyzed an explosion of new information about the genetics of human autoimmunity. In particular, the ability to scan the entire genome for common polymorphisms that associate with disease has led to the identification of numerous new risk genes involved in autoimmune phenotypes. Several themes are emerging. Autoimmune disorders have a complex genetic basis; multiple genes contribute to disease risk, each with generally modest effects independently. In addition, it is now clear that common genes underlie multiple autoimmune disorders. There is also heterogeneity among subphenotypes within a disease and across major racial groups. The current crop of genetic associations are only the start of a complete catalog of genetic factors for autoimmunity, and it remains unclear to what extent common variation versus multiple rare variants contribute to disease susceptibility. The current review focuses on recent discoveries within functionally related groups of genes that provide clues to novel pathways of pathogenesis for human autoimmunity.

Citing Articles

MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients.

Maiti A Clin Rev Allergy Immunol. 2024; 67(1-3):58-72.

PMID: 39460899 DOI: 10.1007/s12016-024-09008-z.

A Comprehensive Review of Upper Gastrointestinal Symptom Management in Autoimmune Gastritis: Current Insights and Future Directions.

Singh S, Chakole S, Agrawal S, Shetty N, Prasad R, Lohakare T Cureus. 2023; 15(8):e43418.

PMID: 37706145 PMC: 10496934. DOI: 10.7759/cureus.43418.

VDR Gene Single Nucleotide Polymorphisms and Autoimmunity: A Narrative Review.

Agliardi C, Guerini F, Bolognesi E, Zanzottera M, Clerici M Biology (Basel). 2023; 12(7).

PMID: 37508347 PMC: 10376382. DOI: 10.3390/biology12070916.

Association of Alopecia Areata with Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.

Lien K, Ger T, Chi C Dermatology. 2023; 239(4):523-532.

PMID: 37094565 PMC: 10407832. DOI: 10.1159/000530784.

Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity.

Ackun-Farmmer M, Jewell C Adv Nanobiomed Res. 2023; 3(3).

PMID: 36938103 PMC: 10019031. DOI: 10.1002/anbr.202200135.

References

Klareskog L, Ronnelid J, Lundberg K, Padyukov L, Alfredsson L . Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol. 2008; 26:651-75. DOI: 10.1146/annurev.immunol.26.021607.090244. View

Honda K, Taniguchi T . IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006; 6(9):644-58. DOI: 10.1038/nri1900. View

Simoncic P, Lee-Loy A, Barber D, Tremblay M, McGlade C . The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol. 2002; 12(6):446-53. DOI: 10.1016/s0960-9822(02)00697-8. View

Waid D, Vaitaitis G, Pennock N, Wagner Jr D . Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes. J Leukoc Biol. 2008; 84(2):431-9. PMC: 2493071. DOI: 10.1189/jlb.1207857. View

Shin H, Sung Y, Choi C, Lee S, Lee H, Bae S . Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population. Arthritis Res Ther. 2007; 9(2):R32. PMC: 1906810. DOI: 10.1186/ar2152. View

De Jager P, Sawcer S, Waliszewska A, Farwell L, Wild G, Cohen A . Evaluating the role of the 620W allele of protein tyrosine phosphatase PTPN22 in Crohn's disease and multiple sclerosis. Eur J Hum Genet. 2006; 14(3):317-21. DOI: 10.1038/sj.ejhg.5201548. View

Graham R, Kyogoku C, Sigurdsson S, Vlasova I, Davies L, Baechler E . Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A. 2007; 104(16):6758-63. PMC: 1847749. DOI: 10.1073/pnas.0701266104. View

Dideberg V, Kristjansdottir G, Milani L, Libioulle C, Sigurdsson S, Louis E . An insertion-deletion polymorphism in the interferon regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Hum Mol Genet. 2007; 16(24):3008-16. DOI: 10.1093/hmg/ddm259. View

Mathis D, Benoist C . A decade of AIRE. Nat Rev Immunol. 2007; 7(8):645-50. DOI: 10.1038/nri2136. View

10.

Vandiedonck C, Beaurain G, Giraud M, Hue-Beauvais C, Eymard B, Tranchant C . Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia. Proc Natl Acad Sci U S A. 2004; 101(43):15464-9. PMC: 524438. DOI: 10.1073/pnas.0406756101. View

11.

Gaffney P, Langefeld C, Graham R, Ortmann W, Williams A, Rodine P . Fine-mapping chromosome 20 in 230 systemic lupus erythematosus sib pair and multiplex families: evidence for genetic epistasis with chromosome 16q12. Am J Hum Genet. 2006; 78(5):747-758. PMC: 1474034. DOI: 10.1086/503686. View

12.

Liu-Mares W, Sun Z, Bamlet W, Atkinson E, Fridley B, Slager S . Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated molecules. BMC Proc. 2008; 1 Suppl 1:S126. PMC: 2367504. DOI: 10.1186/1753-6561-1-s1-s126. View

13.

Li J, Moran T, Swanson E, Julian C, Harris J, Bonen D . Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet. 2004; 13(16):1715-25. DOI: 10.1093/hmg/ddh182. View

14.

Kim H, Imbert J, Leonard W . Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 2006; 17(5):349-66. DOI: 10.1016/j.cytogfr.2006.07.003. View

15.

Nejentsev S, Howson J, Walker N, Szeszko J, Field S, Stevens H . Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature. 2007; 450(7171):887-92. PMC: 2703779. DOI: 10.1038/nature06406. View

16.

Dunn I, Sannikova T, Geha R, Tsitsikov E . Identification and characterization of two CD40-inducible enhancers in the mouse TRAF1 gene locus. Mol Immunol. 2001; 37(16):961-73. DOI: 10.1016/s0161-5890(01)00015-3. View

17.

Chao M, Barnardo M, Lincoln M, Ramagopalan S, Herrera B, Dyment D . HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci U S A. 2008; 105(35):13069-74. PMC: 2529028. DOI: 10.1073/pnas.0801042105. View

18.

Tomer Y, Concepcion E, Greenberg D . A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid. 2003; 12(12):1129-35. DOI: 10.1089/105072502321085234. View

19.

Baechler E, Batliwalla F, Karypis G, Gaffney P, Ortmann W, Espe K . Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003; 100(5):2610-5. PMC: 151388. DOI: 10.1073/pnas.0337679100. View

20.

Lee H, Lee A, Criswell L, Seldin M, Amos C, Carulli J . Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus. Mol Med. 2008; 14(5-6):293-300. PMC: 2255558. DOI: 10.2119/2007-00123.Lee. View